In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
出版年份 2019 全文链接
标题
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
作者
关键词
β-Lactamase inhibitor, Carbapenem-resistant, Carbapenemase, Multidrug-resistant, MK-7655, Imipenem/relebactam, Non-susceptible, Antibiotic resistance
出版物
BMC MICROBIOLOGY
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-07-04
DOI
10.1186/s12866-019-1522-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
- (2017) Matthew Sims et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014
- (2017) James A. Karlowsky et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia–Pacific countries: SMART 2013–2015
- (2017) James A. Karlowsky et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from U.S. Medical Centers by Census Region, 2014
- (2016) Michael D. Huband et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of theIn VitroActivity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
- (2016) Deanna J. Buehrle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structural and Functional Aspects of Class A Carbapenemases
- (2016) Thierry Naas et al. CURRENT DRUG TARGETS
- High performance enzyme kinetics of turnover, activation and inhibition for translational drug discovery
- (2016) Rumin Zhang et al. Expert Opinion on Drug Discovery
- Tigecycline antimicrobial activity tested against clinical bacteria from Latin American medical centres: results from SENTRY Antimicrobial Surveillance Program (2011–2014)
- (2016) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012–2014
- (2016) Helio S. Sader et al. Surgical Infections
- Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
- (2016) Kellie Goodlet et al. Therapeutics and Clinical Risk Management
- Kibdelomycin Is a Bactericidal Broad-Spectrum Aerobic Antibacterial Agent
- (2015) Sheo B. Singh et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013
- (2015) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013
- (2015) Douglas J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutant Alleles oflptDIncrease the Permeability of Pseudomonas aeruginosa and Define Determinants of Intrinsic Resistance to Antibiotics
- (2015) Carl J. Balibar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City
- (2015) Amabel Lapuebla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008–2012. Results of the Study for Monitoring Antimicrobial Resistance Trends
- (2015) Krystyna M. Kazmierczak et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The increasing threat of Pseudomonas aeruginosa high-risk clones
- (2015) Antonio Oliver et al. DRUG RESISTANCE UPDATES
- Prevalence and risk factors associated with colonization and infection of extensively drug-resistantPseudomonas aeruginosa: a systematic review
- (2015) Michael Buhl et al. Expert Review of Anti-Infective Therapy
- Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies
- (2015) Mohamed E El Zowalaty et al. Future Microbiology
- Global Assessment of Antimicrobial Susceptibility among Gram-Negative Organisms Collected from Pediatric Patients between 2004 and 2012: Results from the Tigecycline Evaluation and Surveillance Trial
- (2015) Sue C. Kehl et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-��-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea
- (2015) Hye Hyun Cho et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
- (2015) Jürg Dreier et al. Frontiers in Microbiology
- A Systematic Review and Meta-Analyses Show that Carbapenem Use and Medical Devices Are the Leading Risk Factors for Carbapenem-Resistant Pseudomonas aeruginosa
- (2014) A. F. Voor in 't holt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
- (2014) Timothy A. Blizzard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New perspectives in the management of Pseudomonas aeruginosa infections
- (2014) Dianella Savoia Future Microbiology
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: Results from the SENTRY Antimicrobial Surveillance Program, 2009–2012
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011–12)
- (2014) Helio S. Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
- (2014) M. Castanheira et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012)
- (2014) Helio S. Sader et al. JOURNAL OF INFECTION
- Responses of Pseudomonas aeruginosa to antimicrobials
- (2014) Yuji Morita et al. Frontiers in Microbiology
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of Antibiotic Use on Carbapenem Resistance in Pseudomonas aeruginosa: Is There a Role for Antibiotic Diversity?
- (2013) C. Plüss-Suard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure
- (2013) G. Meletis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009
- (2013) Shio-Shin Jean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011
- (2013) Stephen P. Hawser et al. JOURNAL OF INFECTION
- Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa
- (2013) E. Fuste et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Efflux System Overexpression and Decreased OprD Contribute to the Carbapenem Resistance Among Extended-Spectrum Beta-Lactamase-Producing Pseudomonas aeruginosa Isolates from a Chinese University Hospital
- (2013) Yang Liu et al. Microbial Drug Resistance
- In VitroActivity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria
- (2012) Elizabeth B. Hirsch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of β-lactam Resistance Among Pseudomonas aeruginosa
- (2012) Daniel J. Wolter et al. CURRENT PHARMACEUTICAL DESIGN
- Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010
- (2012) Daryl J. Hoban et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010)
- (2012) Ana C. Gales et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Structure and function of OprD protein in Pseudomonas aeruginosa: From antibiotic resistance to novel therapies
- (2012) Hui Li et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dendroscope 3: An Interactive Tool for Rooted Phylogenetic Trees and Networks
- (2012) Daniel H. Huson et al. SYSTEMATIC BIOLOGY
- MexXY multidrug efflux system of Pseudomonas aeruginosa
- (2012) Yuji Morita et al. Frontiers in Microbiology
- In Vitro Activity of Ceftazidime Combined with NXL104 versus Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals (CANWARD 2009 Study)
- (2011) A. Walkty et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenems: Past, Present, and Future
- (2011) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
- (2011) A. R. Hauser et al. CLINICAL MICROBIOLOGY REVIEWS
- Trends in Catheter-Associated Urinary Tract Infections in Adult Intensive Care Units—United States, 1990–2007
- (2011) Deron C. Burton et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
- (2011) F. Sievers et al. Molecular Systems Biology
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
- (2009) J.-M. Rodriguez-Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
- (2009) P. D. Lister et al. CLINICAL MICROBIOLOGY REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now